Leslie Boyer, MD 2013 Arizona Bioscience Researcher of the Year
In 2013, Dr. Leslie Boyer was been named one of 30 heroes of rare diseases by the Food and Drug Administration’s Office of Orphan Products Development. Her work includes a clinical studies program conducted throughout Arizona with protocols for placebo-controlled, double-blind trials, open-label studies, historical control studies, and the statewide STING project. She has coordinated phase 2 and phase 3 multicenter clinical trials of pit viper antivenom, developed the Antivenom Index, and participated in the establishment of the Pan-American Lymphotoxinology Taskforce. Boyer, who is a member of the UA’s BIO5 Institute, has focused her scientific career on venomous bites and stings, which are often unrecognized public health issues. She began by developing public education programs that offer poison and toxin emergency treatment advice. In 2004 and 2005, with an FDA Orphan Product grant, she led a team that conducted clinical studies leading to the marketing approval of the first scorpion antivenom – representing one of more than 40 products developed through orphan grant-sponsored research.
Industrial Biotech in Arizona
Where is Industrial Biotech in Arizona Today? Glen Galster, co-founder of Algae Biosciences and AZBio Chairman of the Board moderates this panel discussion from the AZBio Expo 2012 featuring: Leif P. Christoffersen, Director of Biomass Integration, Yulex Corporation . Ben Cloud, President and CEO, Phyco Biosciences, Inc ., Josh Hottenstein, Cleantech Open
Honoring U.S. Senator Jon Kyl
As Arizona celebrated its Centennial, AZBio honored Arizona Senator Jon Kyl for his dedication and service to both our industry and the people of our state with the 2012 AZBio Centennial Award. Senator Kyl is serving his third and final term in the U.S. Senate after previously serving for eight years in the U.S. House of Representatives. He was elected unanimously by his colleagues in 2008 to serve as Republican Whip, the second-highest position in Senate Republican leadership. Enjoy Senator Kyl's remarks about Arizona's Bioindustry and the introduction by Fritz Bittenbender of the Biotechnology Industry Association (BIO)
Partnering in the New Age of R&D
There is a major shift occurring in our industries with companies large and small. None of us are looking to go it alone in a world where new product development can range from millions to BILLIONS. Again we looked to experts from the front lines for insights... Panelists: Paul August, VP and head of the early to candidate program for Sanofi, US ; Babak Nemat of founder of Strategic Intelligence and advisor to J&J, Bill Mulholland of Snell & Wilmer, Joan Koerber-Walker, AZBio (moderator)